Results 171 to 177 of about 2,000 (177)

An HIV Vaccine in the Era of Twice-Yearly Lenacapavir for PrEP - Essential or Irrelevant?

New England Journal of Medicine
Lauren P. Jatt, N. Mgodi, Susan P. Buchbinder, Glenda E. Gray, J. Kublin   +4 more
semanticscholar   +1 more source

Lenacapavir: A novel injectable HIV-1 capsid inhibitor

International Journal of Antimicrobial Agents
Allison Hitchcock
exaly  

Antiviral Activity of Lenacapavir Against Human Immunodeficiency Virus Type 2 (HIV-2) Isolates and Drug-Resistant HIV-2 Mutants

Journal of Infectious Diseases
Nicolas Margot, Geoffrey Gottlieb, Robert Smith   +2 more
exaly  

Lenacapavir: A Novel Long-Acting Capsid Inhibitor for HIV

Annals of Pharmacotherapy
Elizabeth Sherman, David Koren
exaly  

No antagonism or cross-resistance and a high barrier to the emergence of resistance in vitro for the combination of islatravir and lenacapavir

Antimicrobial Agents and Chemotherapy
Tracy Diamond, Jay A Grobler
exaly  

Rapid Selection of HIV-2 Capsid Mutations in Salvage Therapy With Lenacapavir-containing Regimen

Clinical Infectious Diseases
Nadia Valin, Quentin le Hingrat, Gilles Peytavin   +2 more
exaly  

Synthetic Development and Scale-Up of a Complex Pyrazole Fragment of Lenacapavir

Organic Process Research and Development
Nisha P Shāh, Alexander Goldberg, Nathaniel Kadunce   +2 more
exaly